Novo Nordisk rejects diabetes drug Victoza complaint
COPENHAGEN (Reuters) - Danish drugmaker Novo Nordisk rejected a consumer advocacy group's complaint about its big-selling diabetes drug Victoza as groundless and said it did not expect U.S. regulators to take any action. Its shares initially d...
No comments:
Post a Comment
Note: only a member of this blog may post a comment.